What is the price target for BBNX stock?
18 analysts have analysed BBNX and the average price target is 21 USD. This implies a price increase of 104.03% is expected in the next year compared to the current price of 10.29.
BETA BIONICS INC (BBNX) Forecast, Price Target & Analyst Ratings
NASDAQ:BBNX • US08659B1026
Current stock price
10.29 USD
+0.09 (+0.88%)
At close:
10.29 USD
0 (0%)
After Hours:
Analyst forecast overview
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for BETA BIONICS INC (BBNX).
Forecast Snapshot
Next Earnings Forecast
Earnings Estimate- Release Date
- Jul 27, 2026
- Period
- Q2 / 2026
- EPS Estimate
- -$0.60
- Revenue Estimate
- 32.133M
Price Target Details & History
Consensus Price Target and Range
Mean target
$20.99
Upside
+ 104.03%
From current price of $10.29 to mean target of $20.99, Based on 18 analyst forecasts
Low
$14.14
Median
$20.40
High
$33.60
Price Target Revisions
1 Month
-12.10%
3 Months
-36.86%
Price Target Summary
18 Wall Street analysts provided a forecast for the next 12 months for BBNX. The average price target is 21 USD. This implies a price increase of 104.03% is expected in the next year compared to the current price of 10.29.
The average price target has been revised downward by 36.86% in the past 3 months.
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
82.22%
BBNX was analyzed by 18 analysts. The buy percentage consensus is at 82. So analysts seem to be very confident about BBNX.
In the previous month the buy percentage consensus was at a similar level.
BBNX was analyzed by 18 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
Recent Upgrades & Downgrades
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-04-22 | Leerink Partners | Maintains | Outperform -> Outperform |
| 2026-04-22 | Stifel | Maintains | Buy -> Buy |
| 2026-04-15 | Truist Securities | Maintains | Buy -> Buy |
| 2026-04-09 | Goldman Sachs | Maintains | Buy -> Buy |
| 2026-02-18 | Stifel | Maintains | Buy -> Buy |
| 2026-02-18 | Baird | Maintains | Neutral -> Neutral |
| 2026-02-04 | Stifel | Maintains | Buy -> Buy |
| 2026-02-02 | Truist Securities | Maintains | Buy -> Buy |
| 2026-01-27 | TD Cowen | Initiate | Hold |
| 2026-01-09 | Lake Street | Maintains | Buy -> Buy |
| 2026-01-05 | B of A Securities | Maintains | Buy -> Buy |
| 2025-12-18 | Truist Securities | Maintains | Buy -> Buy |
| 2025-10-29 | Stifel | Reiterate | Buy -> Buy |
| 2025-10-29 | Truist Securities | Reiterate | Buy -> Buy |
| 2025-10-29 | Goldman Sachs | Maintains | Buy -> Buy |
| 2025-10-29 | Piper Sandler | Reiterate | Overweight -> Overweight |
| 2025-10-21 | Stifel | Reiterate | Buy |
| 2025-10-01 | Goldman Sachs | Upgrade | Neutral -> Buy |
| 2025-09-22 | Truist Securities | Maintains | Buy -> Buy |
| 2025-07-30 | Truist Securities | Maintains | Buy -> Buy |
| 2025-07-30 | Baird | Maintains | Neutral -> Neutral |
| 2025-06-16 | Truist Securities | Initiate | Buy |
| 2025-05-30 | Wolfe Research | Initiate | Outperform |
| 2025-05-30 | Goldman Sachs | Initiate | Neutral |
| 2025-02-24 | Leerink Partners | Initiate | Outperform |
Next Earnings Forecast Details
Next Earnings Details
- Release Date
- Jul 27, 2026
- Period
- Q2 / 2026
- EPS Estimate
- -$0.60
- Revenue Estimate
- 32.133M
- Revenue Q2Q
- 38.28%
- EPS Q2Q
- -55.12%
- Number of Analysts
- 13
Next Earnings Revisions
Revenue (1 Month)
-0.03%
Revenue (3 Months)
-0.53%
EPS (1 Month)
-19.62%
EPS (3 Months)
-30.83%
Next Earnings Summary
BBNX is expected to report earnings on 7/27/2026. The consensus EPS estimate for the next earnings is -0.6 USD and the consensus revenue estimate is 32.13M USD.
The next earnings revenue estimate has been revised downward by 0.53% in the past 3 months.
Full Analyst Estimates 2026 - 2032
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 11.995M 6,601.12% | 65.124M 442.93% | 100.251M 53.94% | 135.24M 34.90% | 182.07M 34.63% | 255.3M 40.22% | 362.68M 42.06% | 471.81M 30.09% | 517.14M 9.61% | 634.44M 22.68% | |
| EBITDA YoY % growth | -34.624M 46.32% | -44.1M -27.37% | -70.108M -58.98% | -71.923M -2.59% | -71.511M 0.57% | -42.088M 41.14% | -33.15M 21.24% | -10.608M 68.00% | N/A | N/A | |
| EBIT YoY % growth | -35.85M 45.55% | -45.251M -26.22% | -71.681M -58.41% | -98.423M -37.31% | -99.754M -1.35% | -81.245M 18.56% | -60.18M 25.93% | -25.5M 57.63% | 52.02M 304.00% | 68.34M 31.37% | |
| Operating Margin | -298.87% | -69.48% | -71.50% | -72.78% | -54.79% | -31.82% | -16.59% | -5.40% | 10.06% | 10.77% | |
| EPS YoY % growth | N/A | N/A | -1.94 8.78% | -1.95 -0.59% | -1.96 -0.54% | -1.33 32.04% | -1.93 -44.59% | -1.51 21.69% | N/A | N/A |
All data in USD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | Q1 / 28 | Q2 / 28 | Q3 / 28 | Q4 / 28 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.60 -55.12% | -0.48 -44.13% | -0.47 -63.06% | -0.49 0.58% | -0.48 21.43% | -0.47 1.61% | -0.48 -1.55% | -0.18 62.31% | -0.19 59.23% | -0.15 67.31% | -0.12 74.51% |
| Revenue Q2Q % growth | 32.133M 38.28% | 35.526M 30.36% | 39.983M 24.48% | 38.322M 38.72% | 42.789M 33.16% | 47.563M 33.88% | 54.128M 35.38% | 57.13M 49.08% | 61.241M 43.12% | 66.341M 39.48% | 72.593M 34.11% |
| EBITDA Q2Q % growth | -21.876M -13.81% | -16.672M -4.15% | -15.73M -8.10% | -16.176M 31.70% | -16.3M 25.49% | -17.144M -2.83% | -17.376M -10.47% | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -28.916M -45.51% | -24.08M -41.29% | -23.684M -46.89% | -23.916M 1.46% | -24.675M 14.67% | -23.68M 1.66% | -24.265M -2.46% | -11.159M 53.34% | -11.873M 51.88% | -9.578M 59.55% | -7.844M 67.67% |
All data in USD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
9.49%
EPS Next 5 Year
4.09%
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
36.48%
Revenue Next 5 Year
36.27%
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
13.38%
EBIT Next 5 Year
13.25%
BETA BIONICS INC / BBNX Forecast FAQ
When does BETA BIONICS INC (BBNX) report earnings?
BETA BIONICS INC (BBNX) will report earnings on 2026-07-27.
What are the consensus estimates for BETA BIONICS INC (BBNX) next earnings?
The consensus EPS estimate for the next earnings of BETA BIONICS INC (BBNX) is -0.6 USD and the consensus revenue estimate is 32.13M USD.
What is the consensus rating for BETA BIONICS INC (BBNX) stock?
The consensus rating for BETA BIONICS INC (BBNX) is 82.2222 / 100 . This indicates that analysts generally have a positive outlook on the stock.